BACKGROUND: Previous research suggests that cancer patients frequently experience multiple symptoms during chemotherapy; however, relationships among symptom changes are largely unknown. PURPOSE: The aim of the current study was to examine daily and intraday changes and interrelationships among fatigue, depression, and objectively measured disruptions in sleep and activity during chemotherapy. METHODS: Participants were 78 women with gynecologic cancer. Fatigue, depression, sleep, and activity were assessed the week before and the week after the participants' first three infusions. RESULTS: Significant changes in fatigue, depression, sleep, and activity were observed over time. Before infusions, increases in fatigue were associated with increases in depression. After infusions, increases in fatigue were associated with increases in depression and minutes awake at night, as well as decreases in daytime activity and regularity of sleep/activity patterns (ps < .05). CONCLUSIONS: This study is among the first to track daily and intraday changes in symptoms and interrelationships during chemotherapy. Results indicate that symptoms are interrelated and return to baseline levels after infusions.
BACKGROUND: Previous research suggests that cancerpatients frequently experience multiple symptoms during chemotherapy; however, relationships among symptom changes are largely unknown. PURPOSE: The aim of the current study was to examine daily and intraday changes and interrelationships among fatigue, depression, and objectively measured disruptions in sleep and activity during chemotherapy. METHODS:Participants were 78 women with gynecologic cancer. Fatigue, depression, sleep, and activity were assessed the week before and the week after the participants' first three infusions. RESULTS: Significant changes in fatigue, depression, sleep, and activity were observed over time. Before infusions, increases in fatigue were associated with increases in depression. After infusions, increases in fatigue were associated with increases in depression and minutes awake at night, as well as decreases in daytime activity and regularity of sleep/activity patterns (ps < .05). CONCLUSIONS: This study is among the first to track daily and intraday changes in symptoms and interrelationships during chemotherapy. Results indicate that symptoms are interrelated and return to baseline levels after infusions.
Authors: Bernhard Holzner; Georg Kemmler; Verena Meraner; Andrea Maislinger; Martin Kopp; Thomas Bodner; Dominic Nguyen-Van-Tam; Alain G Zeimet; W Wolfgang Fleischhacker; Barbara Sperner-Unterweger Journal: Cancer Date: 2003-03-15 Impact factor: 6.860
Authors: G A Curt; W Breitbart; D Cella; J E Groopman; S J Horning; L M Itri; D H Johnson; C Miaskowski; S L Scherr; R K Portenoy; N J Vogelzang Journal: Oncologist Date: 2000
Authors: Joseph A Roscoe; Gary R Morrow; Jane T Hickok; Peter Bushunow; Sara Matteson; Dmitry Rakita; Paul L R Andrews Journal: Support Care Cancer Date: 2001-11-28 Impact factor: 3.603
Authors: Marie-Christine Mormont; Anne Marie Langouët; Bruno Claustrat; André Bogdan; Sylvie Marion; Jim Waterhouse; Yvan Touitou; Francis Lévi Journal: Chronobiol Int Date: 2002-01 Impact factor: 2.877
Authors: Ann M Berger; Kimberly Wielgus; Melody Hertzog; Patricia Fischer; Lynne Farr Journal: Support Care Cancer Date: 2009-04-19 Impact factor: 3.603
Authors: Doerte U Junghaenel; Jules Cohen; Stefan Schneider; Anu R Neerukonda; Joan E Broderick Journal: Support Care Cancer Date: 2015-01-27 Impact factor: 3.603
Authors: Meredith E Rumble; Stephen L Rose; Kaitlin Hanley White; A Holliston Moore; Philip Gehrman; Ruth M Benca; Erin S Costanzo Journal: Gynecol Oncol Date: 2015-04-21 Impact factor: 5.482
Authors: Heather S L Jim; Paul B Jacobsen; Kristin M Phillips; Robert M Wenham; William Roberts; Brent J Small Journal: Health Psychol Date: 2013-02-25 Impact factor: 4.267
Authors: Laurie E Steffen; Jennifer S Cheavens; Kevin E Vowles; Jennifer Gabbard; Huynh Nguyen; Gregory N Gan; Martin J Edelman; Bruce W Smith Journal: Support Care Cancer Date: 2019-06-01 Impact factor: 3.603
Authors: Anand Dhruva; Bradley E Aouizerat; Bruce Cooper; Steven M Paul; Marylin Dodd; Claudia West; William Wara; Kathryn Lee; Laura B Dunn; Dale J Langford; John D Merriman; Christina Baggott; Janine Cataldo; Christine Ritchie; Kord Kober; Heather Leutwyler; Christine Miaskowski Journal: Eur J Oncol Nurs Date: 2013-09-05 Impact factor: 2.398
Authors: Fay Wright; Gail D'Eramo Melkus; Marilyn Hammer; Brian L Schmidt; M Tish Knobf; Steven M Paul; Frances Cartwright; Judy Mastick; Bruce A Cooper; Lee-May Chen; Michelle Melisko; Jon D Levine; Kord Kober; Bradley E Aouizerat; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2015-03-28 Impact factor: 3.612
Authors: Kord M Kober; Betty Smoot; Steven M Paul; Bruce A Cooper; Jon D Levine; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2016-09-21 Impact factor: 3.612
Authors: Kristin M Phillips; Leigh Anne Faul; Brent J Small; Paul B Jacobsen; Sachin M Apte; Heather S L Jim Journal: J Pain Symptom Manage Date: 2012-11-15 Impact factor: 3.612
Authors: Stephanie J Sohl; Suzanne C Danhauer; Gurjeet S Birdee; Barbara J Nicklas; George Yacoub; Mebea Aklilu; Nancy E Avis Journal: Complement Ther Med Date: 2016-04 Impact factor: 2.446